Abdul Mannan: Venous Thromboembolism Prophylaxis Is Often Overlooked in Medical Inpatients
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Venous thromboembolism remains a leading cause of preventable hospital deaths, yet prophylaxis is often overlooked in medical inpatients. Evidence shows that systematic risk assessment using tools like the Padua Score, combined with bleeding-risk stratification (IMPROVE), saves lives. Pharmacological prophylaxis with LMWH reduces VTE by up to 50% in at-risk patients, whilst mechanical methods offer alternatives when bleeding risk is high. As clinicians, we must embed VTE assessment into daily practice—document decisions, reassess regularly, and champion mechanical prophylaxis when pharmacological options are contraindicated. Let’s ensure every patient receives the right prophylaxis at the right time. Prevention is always better than treatment.”
Learn more here.
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 17, 2025, 15:24Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
-
Dec 17, 2025, 15:01WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
-
Dec 17, 2025, 14:44Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
-
Dec 17, 2025, 14:29Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID